Epinephrine 0.3 MG auto-inject 2S
Ended Awarded Last action
- Contract number
- SPE2DR26FG1QF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,695
Award facts
- Contract value 100% obligated
- $9,695.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a contract ceiling value of $9,695.03 and a firm fixed price structure. The order is non-competitive and scheduled for completion by December 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's significant contract portfolio with the Defense Logistics Agency reflects its capability to meet federal procurement requirements and serve customers including the Defense Health Agency and U.S. Coast Guard. As the DLA Troop Support transitions to establishing Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, AmerisourceBergen Drug Corp remains positioned as a primary vendor for critical medical commodities supporting U.S. military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FG1QF?
SPE2DR26FG1QF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FG1QF worth?
The government has obligated $9,695 on SPE2DR26FG1QF.
Is contract SPE2DR26FG1QF an order under another contract?
Yes. SPE2DR26FG1QF is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1QF competed?
The extent of competition for SPE2DR26FG1QF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award